Imagine your DRG claims are grouping, dropping, and paying without a single denial attached. Sounds good, right? Unfortunately, zero denials doesn’t mean zero errors.
A claim that pays clean can still carry the wrong DRG, and nothing in a standard coding, AR, or denial workflow is built to notice.
This guide breaks down what a DRG validation review actually checks and how it uncovers revenue at risk. You’ll see why a claim’s DRG assignment doesn’t confirm the underlying codes are accurate. Then I’ll show you five checks for catching documentation gaps early, and how to get your DRG review program started.
A coding accuracy review published by the Healthcare Financial Management Association put a dollar figure on what coding errors cost hospitals in lost DRG revenue. Across just 612 inpatient cases, inaccurate ICD-10 coding created a potential loss of $1.149 million – an average of $1,877 per case.
Multiply that average per-case loss across every CC/MCC-eligible diagnosis and every DRG family in a hospital’s inpatient volume, and the potential scale of what a standard coding or AR workflow misses starts to come into focus.
That’s the real risk. This loss never shows up as a denial, an appeal, or a line item anyone tracks. It simply becomes revenue the hospital never collected and never knew was there.
MS-DRG assignment runs on the codes submitted, not on whether those codes reflect the chart. The grouper takes principal diagnosis, secondary diagnoses, procedures performed, discharge status, and present-on-admission (POA) indicators, and assigns a single DRG under 42 CFR 412.60. It has no mechanism to check whether the documentation supports what’s on the claim – that’s a separate question entirely, and one grouping logic was never built to answer.
Two failure modes look identical on a claim and get treated as one problem, when they need different reviewers. A coding-based DRG downgrade means a code was assigned or sequenced incorrectly against the medical record and ICD-10-CM/PCS guidelines; for example, a principal diagnosis doesn’t reflect the condition chiefly responsible for the admission. That’s a coder’s question. A clinical validation gap means the code may be defensible on the chart, but the documented clinical evidence doesn’t clearly support it – a clinician’s question.
Sepsis shows the difference clearly. According to a recent legal analysis of hospital DRG disputes, a case can be coded correctly under the broader Sepsis-2 criteria and still get challenged if a reviewer applies the narrower Sepsis-3 criteria instead; payers applying Sepsis-3 as a coding standard are applying a criteria set CMS itself hasn't adopted for that purpose. Same chart, same code, two different clinical standards — which is exactly why validation review needs clinical judgment, not just a coding-rules check.
Payers know this distinction well, and they’re scaling their side of it. Commercial and Medicare Advantage plans are expanding automated, AI-assisted tools built to compare coded severity against clinical documentation at a scale manual review can’t match. The same legal analysis names where that scrutiny concentrates: sepsis (DRGs 871–873), acute kidney injury and renal failure (682–684), malnutrition (951–953), and encephalopathy or stroke-related conditions (064–066). If your validation review isn’t already weighted toward those categories, it’s missing where the actual challenges land.
1. Prioritize reviews by risk. Run concurrent or retrospective reviews prioritized by DRG, MDC, and dollar threshold. Compare the coded DRG against the documentation for principal diagnosis selection, CC/MCC support, procedure accuracy, and POA indicators, including procedure codes that shift a case into or out of a surgical DRG. Start with your highest-scrutiny categories and highest-dollar DRGs, not every discharge at once.
2. Build a physician query workflow with one rule: If documentation doesn’t clearly support the coded severity, the case gets a clarifying query before bill drop. Closing the gap pre-bill costs far less than defending it after a payer challenge. Note: The query has to be compliant, meaning non-leading, under AHIMA/ACDIS query practice standards. A workflow that just says 'query when documentation is thin' without that guardrail can itself become a compliance exposure.
3. Automate risk flagging. Build or contract for analytics that flag high-risk DRGs and MDCs automatically. Two signals do most of the work: diagnoses that frequently appear without supporting clinical indicators, and DRGs where CC/MCC capture rates lag your peer benchmark.
4. Train coding and CDI staff on the same clinical validation criteria payers use. If your internal standard is looser than what gets tested externally, you’re finding a different and less useful set of errors than the ones a payer will find.
5. Feed findings into downcode defense. Patterns by DRG, payer, and clinical scenario should shape appeal language and documentation strategy, not sit in a separate workstream from denial management.
DRG validation isn’t a coding-rules exercise you can run with coders alone. It requires an expert who can read a chart the way a clinician does, judging whether the documented picture actually supports the coded severity. That’s a different skill set than required for a standard coding compliance review, and it’s a capability many hospitals haven’t staffed for.
Reviewing every discharge at that level of scrutiny isn’t realistic for a team already stretched across denials and AR. If a full concurrent program isn’t feasible right now, triage: run a retrospective pass on the DRGs seeing the heaviest payer scrutiny — sepsis, AKI, malnutrition, encephalopathy — before expanding further.
A narrow, consistent review that actually gets done beats a comprehensive one that never launches.
EnableComp’s team of DRG validation experts pairs clinical judgment with coding precision in every review. Purpose-built technology scans every claim against the same clinical criteria payers use to challenge a DRG at a scale manual review can’t match.
Because we run DRG validation and DRG downcode defense as one coordinated function rather than two separate services, findings from validation review directly strengthen appeal strategy when a payer challenges a DRG, closing the loop between preventing revenue loss and defending against it.
Schedule a consultation to see how much revenue your validation review could recover.
_____________
Kelsey Taylor, BSN, RN, is the Senior Director of Clinical Denials at EnableComp, bringing over 10 years of experience in healthcare management and clinical operations to the role. Her background spans clinical quality, care management, and product management, giving her a well-rounded lens on how revenue cycle, training, and clinical operations intersect. She’s passionate about empowering teams to deliver patient-centered, impactful results and frequently speaks on topics like DRG revenue integrity, complex revenue recovery, and denial prevention strategy.
_____________
A DRG validation review checks whether a claim's coded DRG is supported by the medical record, covering principal diagnosis selection, CC/MCC support, procedure accuracy, and POA indicators. It catches errors that pay clean but don't reflect the chart.
A coding-based DRG downgrade means a code was assigned or sequenced incorrectly against ICD-10-CM/PCS guidelines, which is a coder's question. A clinical validation gap means the code may be defensible on the chart, but the documented evidence doesn't clearly support the coded severity, which is a clinician's question.
The DRGs facing the heaviest payer scrutiny are sepsis (871–873), acute kidney injury and renal failure (682–684), malnutrition (951–953), and encephalopathy or stroke-related conditions (064–066). These categories see the most clinical validation challenges.
Ideally, hospitals should run DRG validation reviews continuously. The strongest approach is concurrent review, checking cases pre-bill and prioritized by DRG, MDC, and dollar threshold
Yes, a claim can be coded correctly and still get challenged. A sepsis case coded correctly under Sepsis-2 criteria can be challenged if a payer applies the narrower Sepsis-3 criteria, which CMS hasn't adopted as a coding standard. Same chart, same code, two different clinical standards.